{"DataElement":{"publicId":"2585220","version":"1","preferredName":"Chronic Graft Versus Host Disease Other Characteristic Type","preferredDefinition":"Text term(s) to identify indicators, clinical manifestations, and/or complications related to cGVHD (chronic Graft vs. Host Disease) not otherwise identified.","longName":"CGVHD_OXT_CHAR_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2180967","version":"1","preferredName":"Chronic Graft Versus Host Disease Assessment","preferredDefinition":"The assessment of the transplant recipient for signs and symptoms of chronic Graft versus Host Disease (GVHD).","longName":"CHR_GVHD_ASSESS","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2206479","version":"1","preferredName":"Chronic Graft Versus Host Disease","preferredDefinition":"A disease or condition that persists or progresses over a long period of time.:Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","longName":"C14141:C0018133","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C0018133","definition":"Graft-versus-host disease. A reaction of donated bone marrow or peripheral stem cells against a person's tissue.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F6D6-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2178813","version":"1","preferredName":"Assessment","preferredDefinition":"The final result of a determination of the value, significance, or extent of.","longName":"Assessment","context":"CCR","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE26673C-624D-3309-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-11","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Added Concept Code AA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2F0AC9A-514D-3D8A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2585208","version":"1","preferredName":"Chronic Graft Versus Host Disease Other Characteristic Type","preferredDefinition":"Text terms to identify indicators, clinical manifestations, or complications related to cGVHD (chronic Graft vs. Host Disease) not otherwise identified.","longName":"CGVHD_OTX_CHAR_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Coronary artery involvement","valueDescription":"Coronary artery involvement","ValueMeaning":{"publicId":"2585209","version":"1","preferredName":"Coronary artery involvement","longName":"2585209","preferredDefinition":"Coronary artery involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9AF6-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9B10-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Eosinophilia > 500/ul","valueDescription":"Eosinophilia > 500/microLiter","ValueMeaning":{"publicId":"2585210","version":"1","preferredName":"Eosinophilia > 500/microLiter","longName":"2585210","preferredDefinition":"Eosinophilia > 500/microLiter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9B1C-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9B36-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Peripheral Neuropathy","valueDescription":"NEUROPATHY","ValueMeaning":{"publicId":"2570463","version":"1","preferredName":"NEUROPATHY","longName":"2570463","preferredDefinition":"A disorder affecting the cranial nerves or the peripheral nervous system.  It is manifested with pain, tingling, numbness, and muscle weakness.  It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathy","conceptCode":"C4731","definition":"A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E04C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9B4F-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Pleural Effusion(s)","valueDescription":"Pleural effusion","ValueMeaning":{"publicId":"2562718","version":"1","preferredName":"Pleural effusion","longName":"2562718","preferredDefinition":"Pleural effusion","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleural Effusion","conceptCode":"C3331","definition":"Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C20B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"KUMMEROA","dateModified":"2022-12-13","changeDescription":null,"administrativeNotes":"20212.12.13 Alt VM Named added for ticket requestCADSR0001786. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9B64-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Cardiomyopathy","valueDescription":"Cardiomyopathy","ValueMeaning":{"publicId":"2585212","version":"1","preferredName":"Cardiomyopathy","longName":"2585212","preferredDefinition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiomyopathy","conceptCode":"C34830","definition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9B74-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9B8C-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Nephrotic syndrome","valueDescription":"nephrotic syndrome","ValueMeaning":{"publicId":"2563201","version":"1","preferredName":"nephrotic syndrome","longName":"2563201","preferredDefinition":"nephrotic syndrome","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nephrotic Syndrome","conceptCode":"C34845","definition":"A collection of symptoms that include severe edema, proteinuria, and hypoalbuminemia; it is indicative of renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C3EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9B98-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Pericardial Effusion","valueDescription":"Pericardial effusion","ValueMeaning":{"publicId":"2562752","version":"1","preferredName":"Pericardial effusion","longName":"2562752","preferredDefinition":"Fluid collection within the pericardial sac, usually due to inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericardial Effusion","conceptCode":"C3319","definition":"Fluid collection within the pericardial sac, usually due to inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C22D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9BAE-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Progressive onset","valueDescription":"Progressive Onset","ValueMeaning":{"publicId":"2573185","version":"1","preferredName":"Progressive Onset","longName":"2573185","preferredDefinition":"Progressive Onset of GVHD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EAEE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-17","modifiedBy":"REEVESD","dateModified":"2005-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9BC4-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"268BF7BB-FC1B-36F1-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Platelets <100,000/uL","valueDescription":"Platelets <100,000/microLiter","ValueMeaning":{"publicId":"2585213","version":"1","preferredName":"Platelets <100,000/microLiter","longName":"2585213","preferredDefinition":"Platelets <100,000/microLiter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9BE6-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9C00-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Polymyositis","valueDescription":"Polymyositis","ValueMeaning":{"publicId":"2585215","version":"1","preferredName":"Polymyositis","longName":"2585215","preferredDefinition":"Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY, NERVOUS SYSTEM); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymyositis","conceptCode":"C26925","definition":"An idiopathic inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness and elevated skeletal muscle enzymes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9C0F-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9C27-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Myasthenia Gravis","valueDescription":"myasthenia gravis","ValueMeaning":{"publicId":"2579902","version":"1","preferredName":"myasthenia gravis","longName":"2579902v1.00","preferredDefinition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness. It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis","conceptCode":"C60989","definition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness. It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-052B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9C43-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Ascites (serositis)","valueDescription":"Ascites (serositis)","ValueMeaning":{"publicId":"2585217","version":"1","preferredName":"Ascites (serositis)","longName":"2585217","preferredDefinition":"Ascites (serositis)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9C4F-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9C69-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Esophageal stricture or web","valueDescription":"Esophageal stricture or web","ValueMeaning":{"publicId":"2585218","version":"1","preferredName":"Esophageal stricture or web","longName":"2585218","preferredDefinition":"Esophageal stricture or web","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9C75-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2687D788-9C8F-74B4-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Cardiac Conduction Defects","valueDescription":"Cardiac Conduction Defects","ValueMeaning":{"publicId":"2585262","version":"1","preferredName":"Cardiac Conduction Defects","longName":"2585262","preferredDefinition":"Cardiac Conduction Defects","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"268BF7BB-FBEC-36F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"268BF7BB-FC06-36F1-E044-0003BA3F9857","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"REEVESD","dateModified":"2007-01-08","deletedIndicator":"No"},{"value":"Weight loss w/o GI Symptoms","valueDescription":"Weight Loss without Gastrointestinal Symptoms","ValueMeaning":{"publicId":"5572690","version":"1","preferredName":"Weight Loss without Gastrointestinal Symptoms","longName":"5572690","preferredDefinition":"Used to indicate the absence or lack of something or someone.: Pertaining to the stomach and intestines.: Subjective evidence of disease perceived by the patient.: A reduction in total body weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Weight Loss","conceptCode":"C3445","definition":"A reduction in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"40E2A335-F4AA-40F0-E053-F662850A2358","latestVersionIndicator":"Yes","beginDate":"2016-11-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"40E2A335-F4C3-40F0-E053-F662850A2358","beginDate":"2016-11-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-11-09","modifiedBy":"ONEDATA","dateModified":"2016-11-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2585207","version":"1","preferredName":"Chronic Graft Versus Host Disease Other Characteristics Type","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation.:Not otherwise specified.:Characteristics; distinguishing qualities of a person, object, or substance.:Type; a subdivision of a particular kind of thing.","longName":"C4981:C17649:C25447:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Characteristic","conceptCode":"C25447","definition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D762-D83D-692E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"ONEDATA","dateModified":"2007-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D762-D84E-692E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"COOPERM","dateModified":"2016-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"NHLBI","type":"USED_BY","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Other indicators, manifestati","type":"Preferred Question Text","description":"Other indicators, manifestations or complications of cGVHD","url":null,"context":"CCR"},{"name":"Other","type":"Application Standard Question Text","description":"Other","url":null,"context":"NHLBI"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2687E852-2C20-02EC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"MALUMK","dateModified":"2021-08-12","changeDescription":"Curated to support NIH cGVHD Scoring Sheet addition to C3D by CCR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}